Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Genprex Inc
GNPX
Healthcare
Biotechnology
Genprex, Inc. is a clinical-stage gene therapy company. The Company is focused on the development of gene-based therapies for patients with unmet medical needs. The Company's lead oncology drug candidate, REQORSA Immunogen therapy drug (quaratusugene ozeplasmid), is being developed to treat non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). The active agent in REQORSA is a...
plasmid that expresses a tumor suppressor gene named TUSC2. REQORSA consists of the TUSC2 gene-expressing plasmid encapsulated in non-viral nanoparticles made from lipid molecules (its ONCOPREX Nanoparticle Delivery System). The Company is also using a different gene therapy delivery system in developing its pre-clinical diabetes candidates, GPX-002 and GPX-003. Its diabetes gene therapy is designed to work by transforming alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body's immune system.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:GNPX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 06, 2024 9:19am
GNPX ...on watch NR
No vol
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 06, 2024 8:30am
New Press Release - Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting
Reqorsa® Immunogene Therapy May be a Potential Therapy for ALK-Positive Lung CancerREQORSA has Anti-Tumor Mechanisms that Target and Disrupt the Metabolism of Cancer CellsNPRL2 Gene Therapy Induces Effective Anti-Tumor Immunity in Non-Small Cell Lung Cancer Humanized Mouse ModelAUSTIN, Texas...
read article.
Fresh Insight into the Topaz Helium Project's Expected Size and Scale
posted Apr 26, 2024 9:00am by
Pulsar Helium Inc.
-
|
The prospective zone is very broad. We believe its not just an isolated occurrence but is actually something quite regionally extensive ...read more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 07, 2024 8:16am
New Press Release - Genprex Expands Nonclinical Programs into New Therapeutic Indications with Research Collaborators
Reqorsa® Therapy May Be Potential Treatment for ALK-Positive Lung CancerThree Collaborators Selected to Present Positive Nonclinical Data on Genprex Oncology Program at the 2024 American Association for Cancer Research (AACR) Annual MeetingAUSTIN, Texas, Feb. 7, 2024 /PRNewswire/ -- Genprex, Inc....
read article.
(83)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 06, 2024 6:45pm
Genprex to Present at Upcoming BIO CEO & Investor Conference
Just In: $GNPX Genprex to Present at Upcoming BIO CEO & Investor ConferenceGenprex to Present at Upcoming BIO CEO @ Investor Conference Genprex to Present at Upcoming BIO CEO @ Investor Conference
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 06, 2024 7:32am
New Press Release - Genprex to Present at Upcoming BIO CEO & Investor Conference
Presentation to Highlight Company's Gene Therapies for Cancer and DiabetesAUSTIN, Texas, Feb. 6, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and...
read article.
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 05, 2024 2:04pm
GNPX.... Very low volume...price action is trending higher
Looks like Mr. M is going to buy my sub $6 paper....Thanks Mr. M Cheers !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 05, 2024 12:33pm
GNPX....say goodbye to Hollywood
It's all over now
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Feb 05, 2024 12:20pm
RE:GNPX...just to prove my point ; )
5 minutes later 1,321,855 shs traded.....last at $6.10 in 5 minutes there was a volume of 1,118 shs Wow
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 05, 2024 12:16pm
GNPX...just to prove my point ; )
At 9:13 a.m pst there was 1,320,737 shs traded.....last at $6.07 I will update after 5 min Keep doing your magic Mr. Maggot
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Feb 05, 2024 12:12pm
RE:GNPX.....dead cat bounce.... on zero volume ; )
The Trend is your friend....til it ain't Still zero volume....sell into Mr. M's manip
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 05, 2024 11:45am
GNPX.....dead cat bounce.... on zero volume ; )
LoL
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 05, 2024 10:52am
GNPX....The Maggot just gave all the Chasers a huge haircut
Get used to it LoL
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Feb 05, 2024 10:32am
RE:GNPX....P.O set up
Told ya.....It's all a pile of excrement
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Feb 05, 2024 10:27am
RE:GNPX.....This could still ramp up
Disregard.....volume is declining Hurry up and wait
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 05, 2024 10:00am
GNPX.....This could still ramp up
Doesn't matter what I say....Mr. M never loses currently $7 No position
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Fresh Insight into the Topaz HELIUM Project's Expected Size and Scale
Exploration company provides project portfolio update
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil